215 related articles for article (PubMed ID: 10346868)
21. Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice.
Hnatowich DJ; Mardirossian G; Fogarasi M; Sano T; Smith CL; Cantor CR; Rusckowski M; Winnard P
J Pharmacol Exp Ther; 1996 Jan; 276(1):326-34. PubMed ID: 8558450
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
Yang W; Mou T; Zhang X; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY
J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
[TBL] [Abstract][Full Text] [Related]
24. Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide.
Karczmarczyk U; Garnuszek P; Maurin M; Di Gialleonardo V; Galli F; Signore A; Mikołajczak R
Nucl Med Biol; 2010 Oct; 37(7):795-803. PubMed ID: 20870154
[TBL] [Abstract][Full Text] [Related]
25. 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.
Shi J; Jia B; Liu Z; Yang Z; Yu Z; Chen K; Chen X; Liu S; Wang F
Bioconjug Chem; 2008 Jun; 19(6):1170-8. PubMed ID: 18491928
[TBL] [Abstract][Full Text] [Related]
26. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
27. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
Li Y; Tan T; Zheng J; Zhang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
[TBL] [Abstract][Full Text] [Related]
29. RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging.
Edwards DS; Liu S; Ziegler MC; Harris AR; Crocker AC; Heminway SJ; Barrett JA; Bridger GJ; Abrams MJ; Higgins JD
Bioconjug Chem; 1999; 10(5):884-91. PubMed ID: 10502357
[TBL] [Abstract][Full Text] [Related]
30. Assessment of macrocyclic triamine ligands as synthons for organometallic 99mTc radiopharmaceuticals.
Suzuki K; Shimmura N; Thipyapong K; Uehara T; Akizawa H; Arano Y
Inorg Chem; 2008 Apr; 47(7):2593-600. PubMed ID: 18269240
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection.
Babich JW; Solomon H; Pike MC; Kroon D; Graham W; Abrams MJ; Tompkins RG; Rubin RH; Fischman AJ
J Nucl Med; 1993 Nov; 34(11):1964-74. PubMed ID: 8229242
[TBL] [Abstract][Full Text] [Related]
32. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
33. Renal metabolism of 111In-DTPA-D-Phe1-octreotide in vivo.
Akizawa H; Arano Y; Uezono T; Ono M; Fujioka Y; Uehara T; Yokoyama A; Akaji K; Kiso Y; Koizumi M; Saji H
Bioconjug Chem; 1998; 9(6):662-70. PubMed ID: 9815158
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-labeled medium-chain fatty acid analogues metabolized by beta-oxidation: radiopharmaceutical for assessing liver function.
Yamamura N; Magata Y; Arano Y; Kawaguchi T; Ogawa K; Konishi J; Saji H
Bioconjug Chem; 1999; 10(3):489-95. PubMed ID: 10346882
[TBL] [Abstract][Full Text] [Related]
35. The Influence of Co-Ligands on Improving Tumor Targeting of
Torabizadeh SA; Hosseinimehr SJ
Mini Rev Med Chem; 2017; 17(2):86-94. PubMed ID: 27515713
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG.
Callahan RJ; Barrow SA; Abrams MJ; Rubin RH; Fischman AJ
J Nucl Med; 1996 May; 37(5):843-6. PubMed ID: 8965158
[TBL] [Abstract][Full Text] [Related]
37. Chemoselective hydrazone formation between HYNIC-functionalized peptides and (18)F-fluorinated aldehydes.
Bruus-Jensen K; Poethko T; Schottelius M; Hauser A; Schwaiger M; Wester HJ
Nucl Med Biol; 2006 Feb; 33(2):173-83. PubMed ID: 16546671
[TBL] [Abstract][Full Text] [Related]
38. In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA).
Mardirossian G; Lei K; Rusckowski M; Chang F; Qu T; Egholm M; Hnatowich DJ
J Nucl Med; 1997 Jun; 38(6):907-13. PubMed ID: 9189140
[TBL] [Abstract][Full Text] [Related]
39.
Masteri Farahani A; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Chem Biol Drug Des; 2020 Aug; 96(2):850-860. PubMed ID: 32279449
[TBL] [Abstract][Full Text] [Related]
40. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
